Giving children a voice in clinical trials

June 15, 2017

Children as young as 8 years old with incurable cancer can reliably characterize the impact an experimental therapy has on their symptoms and quality of life - even at the earliest stages of drug development - making self-reported patient outcomes a potential new clinical trial endpoint, according to a longitudinal validity study led by Children's National Health System researchers.

Cancer is the No. 1 disease-related cause of death in U.S. aged 1 to 19, and roughly 25 percent of the 12,400 children newly diagnosed with cancer will die of their disease, the study authors write.

"When experimental cancer drugs are studied, researchers collect details about how these promising therapies affect children's organs, but rarely do they ask the children themselves about symptoms they feel or the side effects they experience," says Pamela S. Hinds, Ph.D., R.N., director of Nursing Research and Quality Outcomes at Children's National and lead author of study published June 5, 2017 in the journal Cancer. "Without this crucial information, the full impact of the experimental treatment on the pediatric patient is likely underreported and clinicians are hobbled in their ability to effectively manage side effects."

To demonstrate the feasibility of children self-reporting outcomes, Hinds and colleagues recruited children and adolescents aged 8 to 18 with incurable or refractory cancers who were enrolled in Phase 1 safety trials or Phase 2 efficacy trials at four cancer settings: Children's National, Seattle Children's Hospital, Children's Hospital of Philadelphia and Boston Children's Hospital. Using a validated instrument to measure symptoms, function and other aspects of quality of life reported by patients, as well as four open-ended interview questions, researchers were able to better understand what aspects of symptoms and quality of life were most important to patients at this point in their lives and treatment.

Of the 20 , most were male (60 percent), adolescents (65 percent) and white (70 percent). Thirteen (65 percent) had solid tumors. Patients could describe "a good day" as having fewer side effects from the and fewer interruptions to their lives. "Bad days" were marked by interruptions to their usual activities and missing out on spending time with family and friends due to being at the hospital. A few study participants suggested that researchers add questions related to being away from home, family and friends and the ripple effect of treatment on other family members.

"Only by measuring and understanding self-reported symptoms and function in children and adolescents with can we adequately address threats to their quality of life and improve symptom control and supportive care," Hinds and co-authors conclude. "By giving children a voice in the process, clinicians will be able to better anticipate and manage symptoms and thereby improve life for patients and their families."

Explore further: Children who survive sepsis often experience lingering effects

More information: Pamela S. Hinds et al, Voices of children and adolescents on phase 1 or phase 2 cancer trials: A new trial endpoint?, Cancer (2017). DOI: 10.1002/cncr.30782

Related Stories

Children who survive sepsis often experience lingering effects

May 4, 2017
Survival rates have risen dramatically in recent years among children who develop sepsis, a severe, life-threatening immune reaction to an infection somewhere in the body. But new research being presented at the 2017 Pediatric ...

Yoga may help kids with cancer

January 4, 2017
A yoga program for children with cancer can be carried out even during cancer treatment, and has quality of life (QOL) benefits for the children as well as their parents, suggests a study in Rehabilitation Oncology, official ...

Study shows symptoms linked to poor quality of life in long-term childhood cancer survivors

December 12, 2013
Due to improved treatments and technologies, more children than ever are surviving cancer. Unfortunately, about 70 percent of these children experience late effects from their disease and treatment 30 years after their cancer ...

How is health-related quality of life for kids with postconcussion symptoms?

October 24, 2016
Children with persistent postconcussion symptoms reported lower overall, physical, emotional, social and school quality of life for at least 12 weeks after concussion than children whose concussion symptoms resolved more ...

Site of care may partly explain survival difference between kids and AYAs with leukemia

February 16, 2017
Adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) who were not treated at specialized cancer centers had significantly worse five-year survival compared with children ...

Lung cancer patients whose tumor has spread to the brain could be spared radiotherapy

September 5, 2016
Patients with non-small cell lung cancer which has spread to the brain could be spared whole brain radiotherapy as it makes little or no difference to how long they survive and their quality of life, according to a Cancer ...

Recommended for you

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Suicide molecules kill any cancer cell

October 19, 2017
Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

Fundamental research enhances understanding of major cancer gene

October 19, 2017
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge and the AstraZeneca IMED Biotech Unit reveals ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.